JP2023532536A5 - - Google Patents
Info
- Publication number
- JP2023532536A5 JP2023532536A5 JP2022581521A JP2022581521A JP2023532536A5 JP 2023532536 A5 JP2023532536 A5 JP 2023532536A5 JP 2022581521 A JP2022581521 A JP 2022581521A JP 2022581521 A JP2022581521 A JP 2022581521A JP 2023532536 A5 JP2023532536 A5 JP 2023532536A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition
- item
- mirna inhibitor
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063047090P | 2020-07-01 | 2020-07-01 | |
| US63/047,090 | 2020-07-01 | ||
| PCT/IB2021/055890 WO2022003608A1 (en) | 2020-07-01 | 2021-07-01 | Mirna-485 inhibitor for huntington's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023532536A JP2023532536A (ja) | 2023-07-28 |
| JP2023532536A5 true JP2023532536A5 (https=) | 2024-07-09 |
Family
ID=79315650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022581521A Pending JP2023532536A (ja) | 2020-07-01 | 2021-07-01 | ｍｉＲＮＡ－４８５ハンチントン病の阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230304014A1 (https=) |
| EP (1) | EP4175675A4 (https=) |
| JP (1) | JP2023532536A (https=) |
| KR (1) | KR20230031852A (https=) |
| CN (1) | CN115867290A (https=) |
| AU (1) | AU2021302972A1 (https=) |
| BR (1) | BR112022027040A2 (https=) |
| CA (1) | CA3184043A1 (https=) |
| WO (1) | WO2022003608A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240154159A (ko) | 2023-04-17 | 2024-10-25 | 재단법인 아산사회복지재단 | miR-223을 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물 |
| CN116694562B (zh) * | 2023-08-03 | 2023-11-03 | 四川大学华西医院 | 一种BMEC释放的sEV、其制备方法、用途及药物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018139819A1 (ko) * | 2017-01-26 | 2018-08-02 | 주식회사 바이오오케스트라 | 마이크로 rna를 이용한 뇌 질환 예방 또는 치료 용도 |
| US20230099372A1 (en) * | 2020-02-07 | 2023-03-30 | Biorchestra Co., Ltd. | Use of mirna-485 inhibitors for treating tauopathy |
-
2021
- 2021-07-01 AU AU2021302972A patent/AU2021302972A1/en not_active Abandoned
- 2021-07-01 US US18/003,982 patent/US20230304014A1/en active Pending
- 2021-07-01 CN CN202180046108.2A patent/CN115867290A/zh active Pending
- 2021-07-01 EP EP21831873.1A patent/EP4175675A4/en active Pending
- 2021-07-01 BR BR112022027040A patent/BR112022027040A2/pt not_active Application Discontinuation
- 2021-07-01 JP JP2022581521A patent/JP2023532536A/ja active Pending
- 2021-07-01 WO PCT/IB2021/055890 patent/WO2022003608A1/en not_active Ceased
- 2021-07-01 KR KR1020227046418A patent/KR20230031852A/ko active Pending
- 2021-07-01 CA CA3184043A patent/CA3184043A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Song et al. | Assembly strategy of liposome and polymer systems for siRNA delivery | |
| JP2022538868A5 (https=) | ||
| JP2023532536A5 (https=) | ||
| C Silva et al. | Nucleic acids delivery systems: a challenge for pharmaceutical technologists | |
| Chen et al. | A review of gene therapy delivery systems for intervertebral disc degeneration | |
| Reimondez-Troitiño et al. | Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells | |
| JP2023513188A5 (https=) | ||
| JP2023513190A5 (https=) | ||
| Oryan et al. | Basic concepts, current evidence, and future potential for gene therapy in managing cutaneous wounds | |
| Dar et al. | Systemic delivery of stable siRNA-encapsulating lipid vesicles: optimization, biodistribution, and tumor suppression | |
| Sasaki et al. | Alpha-dystroglycan binding peptide A2G80-modified stealth liposomes as a muscle-targeting carrier for Duchenne muscular dystrophy | |
| JP2024501437A5 (https=) | ||
| JP2023513189A5 (https=) | ||
| Pan et al. | In vitro gene transfection in human glioma cells using a novel and less cytotoxic artificial lipoprotein delivery system | |
| US12582669B2 (en) | Composition controlling pharmacokinetics in the body | |
| JP7481694B2 (ja) | 核酸送達複合体 | |
| Baradaran et al. | A novel method for the development of plasmid DNA-loaded nanoliposomes for cancer gene therapy | |
| Verma et al. | < p style= | |
| CN107823652B (zh) | 一种长循环自组装复合纳米制剂、其制备方法及其用途 | |
| CN113105625B (zh) | 一种琥珀酸维生素e修饰的聚乙烯亚胺衍生物、制备方法及其应用 | |
| US12441999B2 (en) | Hybrid htiRNA/nanoparticle complex and use thereof for treating a disease of the digestive system | |
| JP2023522402A5 (https=) | ||
| JP2024503303A5 (https=) | ||
| US20260078381A1 (en) | Methods for Directing Lipid Nanoparticles in Vivo | |
| Morán et al. | DNA Particles |